Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Aortic Stenosis Pilot Trial
2015-000704-25Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- May 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sevelamer carbonate in aortic stenosis (AS) (3 arms), sponsored by Queen Mary University of London. Primary endpoint: Within-person change in serum phosphate concentration. Started May 2018; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2015-000704-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000704-25.